News
In 2002, Dr. Foster structured a USD $215 million licensing deal, Canada’s largest at the time, for voclosporin for kidney transplant immunosuppression with Hoffman-La Roche.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback